85 related articles for article (PubMed ID: 16001680)
41. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
42. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
43. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
44. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
45. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
46. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
[TBL] [Abstract][Full Text] [Related]
47. Detection of p16 promoter methylation in the serum of oral cancer patients.
Nakahara Y; Shintani S; Mihara M; Hino S; Hamakawa H
Int J Oral Maxillofac Surg; 2006 Apr; 35(4):362-5. PubMed ID: 16298513
[TBL] [Abstract][Full Text] [Related]
48. [Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma].
Yao Q; He XS; Zhang JM; He J
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):28-31. PubMed ID: 16483154
[TBL] [Abstract][Full Text] [Related]
49. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
50. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
51. Detection of vimentin methylation in the serum of patients with gastric cancer.
Shirahata A; Sakuraba K; Kitamura Y; Yokomizo K; Gotou T; Saitou M; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2012 Mar; 32(3):791-4. PubMed ID: 22399595
[TBL] [Abstract][Full Text] [Related]
52. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
53. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
Fukuoka T; Hibi K; Nakao A
Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
[TBL] [Abstract][Full Text] [Related]
54. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
55. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
Shen WJ; Dai DQ; Teng Y; Liu J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
[TBL] [Abstract][Full Text] [Related]
56. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
57. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
58. Phospholipids, tumour marker and beta-CrossLaps in diagnosis of gastric carcinoma.
Oremek GM; Sapoutzis N; Lorenz M
Anticancer Res; 2003; 23(2A):859-63. PubMed ID: 12820314
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis.
Miyazaki T; Murayama Y; Shinomura Y; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Tamura S; Hayashi N
Helicobacter; 2007 Oct; 12(5):523-31. PubMed ID: 17760721
[TBL] [Abstract][Full Text] [Related]
60. Detection of p16 promoter hypermethylation in serum of gastric cancer patients.
Kanyama Y; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Cancer Sci; 2003 May; 94(5):418-20. PubMed ID: 12824886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]